News
SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...
FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...
President Donald Trump’s pick to be U.S. surgeon general has said the nation’s medical and food systems are corrupted by ...
Platform can help predict a woman's five-year risk for developing breast cancer by analyzing routine mammograms ...
AI therapy apps promise easy access to mental health care. But convenience comes with hidden costs we're only just beginning ...
The Trump-Musk bromance, which burned hot during the campaign and for the first few months of Trump’s second term in the ...
Viatris Inc. (NASDAQ:VTRS) became the subject of a securities fraud class action lawsuit filed in the U.S. District Court for ...
President Donald Trump’s pick to be the next U.S. surgeon general has repeatedly said the nation’s medical, health and food ...
ORLANDO, FL / ACCESS Newswire / June 6, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc.
The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.
There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...
23hOpinion
Zacks Investment Research on MSN3 Medical Instruments Stocks Winning Big With GenAI Amid Global GloomOver the past year, advancements in artificial intelligence (AI) and predictive analytics have rapidly revolutionized the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results